Close
Help
Need Help?



Cell & Tissue Transplantation & Therapy Joins COPE

Posted Mon, Sep, 17,2012

Cell & Tissue Transplantation & Therapy has formally joined the Committee on Publishing Ethics.COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In mor...

Continue Reading →

Translational Oncogenomics Added to Gale Academic OneFile

Posted Mon, Sep, 17,2012

Libertas is pleased to announce that Translational Oncogenomics has now been added to Gale's Academic OneFile database.GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Translational Oncogenomics in GALE's Academic OneFile will increase article visibility...

Continue Reading →

Clinical Medicine Insights: Dermatology Now Uses Project Counter Analytics

Posted Mon, Sep, 17,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Dermatology.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal&#...

Continue Reading →

Join the Signal Transduction Insights Peer Reviewer Community

Posted Mon, Sep, 17,2012

Libertas encourages readers to register to join the Signal Transduction Insights peer review group.  Being a volunteer peer reviewer is a great way to support Signal Transduction Insights and assist your colleagues who have submitted manuscripts to the journal.The peer review process has been designed to make this vital task as quick and well-organized as possible so reviewers’ time is ...

Continue Reading →

Substance Abuse: Research and Treatment Email Alerts

Posted Mon, Sep, 17,2012

A key component of Libertas' high quality service to Substance Abuse: Research and Treatment authors and readers is the free email alerts service, which keeps recipients updated on Substance Abuse: Research and Treatment newly published articles and journal news.Email alerts recipients receive short, plain text notifications whenever a new article is published.  Notifications are also pro...

Continue Reading →

Posted in: Libertas Services

Pubmed and Open Access Visibility in Clinical Medicine Insights: Endocrinology and Diabetes

Posted Mon, Sep, 17,2012

Articles published in open access journals like Clinical Medicine Insights: Endocrinology and Diabetes are more visible and likely to receive more citations than articles published in restricted access journals.During August, Pubmed Central statistics showed that Libertas Academica has 1,468 papers available for anyone to download for free. These papers received 38,226 views, including 9,352 downl...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
The review process in Libertas Academica journals is prompt, objective and rigorous.  The entire process is smooth and clear and all the editorial staff are cooperative and professional.  Published papers are of top clinical and scientific value, and high metrics reflect the excellent quality of Libertas Academica's journals.
Dr Antoine Kossaify (USEK NDS University Hospital, Byblos, Lebanon)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results